Status:
UNKNOWN
The Selfie Study- Assessing Novel Markers for Cervical Cancer Screening From Self-collected Samples
Lead Sponsor:
George Washington University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Human Papilloma Virus
Cervical Cancer
Eligibility:
FEMALE
30-69 years
Brief Summary
Cervical cancer is primarily caused by Human Papillomaviruses (HPV). Testing for HPV in cervical samples is now an option for cervical cancer screening. HPV can also be tested from self-collected samp...
Detailed Description
Worldwide, cervical cancer remains the fourth most common cancer and fourth leading cause of cancer deaths among women, with the greatest burden occurring in low-resource settings that lack effective ...
Eligibility Criteria
Inclusion
- Female
- Age 30-69
- Undergoing cervical cancer screening, diagnostic procedure (colposcopy), or treatment (LEEP)
Exclusion
- Pregnancy
- History of Cervical Cancer
- Prior hysterectomy
- Inability to provide informed consent
Key Trial Info
Start Date :
August 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04423679
Start Date
August 15 2020
End Date
August 1 2025
Last Update
October 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Faculty Associates
Washington D.C., District of Columbia, United States, 20037